CASI PHARMACEUTICALS, INC. Proceeds from Common Stock Issued
CASI PHARMACEUTICALS, INC. had Proceeds from Common Stock Issued of $32.50 million as of 2021-03-26, per its 10-Q filed 2021-11-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2023-04-26
- CASI PHARMACEUTICALS, INC. proceeds from issuance of common stock for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- CASI PHARMACEUTICALS, INC. proceeds from issuance of common stock for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
- CASI PHARMACEUTICALS, INC. proceeds from issuance of common stock for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
- CASI PHARMACEUTICALS, INC. proceeds from issuance of common stock for the quarter ending 2016-12-31 was $10.89M.
- CASI PHARMACEUTICALS, INC. proceeds from issuance of common stock for fiscal 2016 was $28.15M.
- CASI PHARMACEUTICALS, INC. proceeds from issuance of common stock for fiscal 2015 was $0.00.
| Period end | Proceeds from Issuance of Common Stock | Proceeds from Issuance of Common Stock 1 month | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|---|---|
| 2021-03-26 | $32.50M 10-Q · filed 2021-11-12 | |||||
| 2021-03-24 | $32.50M 10-Q · filed 2022-08-12 | |||||
| 2020-07-24 | $43.70M 20-F · filed 2023-04-26 | |||||
| 2018-03-31 | $29.30M 10-Q · filed 2018-05-15 | |||||
| 2017-10-31 | $23.86M 10-K · filed 2019-03-29 | |||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $0.00 derived: sum of 2 quarters · filed 2017-11-14 | $0.00 10-Q · filed 2017-11-14 | $10.89M derived: sum of 4 quarters · filed 2017-11-14 | ||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $0.00 10-Q · filed 2017-08-14 | $10.89M derived: sum of 3 quarters · filed 2017-08-14 | $11.90M derived: sum of 4 quarters · filed 2017-11-14 | ||
| 2017-03-31 | $0.00 10-Q · filed 2017-05-15 | $10.89M derived: sum of 2 quarters · filed 2017-05-15 | $11.90M derived: sum of 3 quarters · filed 2017-11-14 | $17.86M derived: sum of 4 quarters · filed 2017-11-14 | ||
| 2016-12-31 | $10.89M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $11.90M derived: sum of 2 quarters · filed 2017-11-14 | $17.86M derived: sum of 3 quarters · filed 2017-11-14 | $28.15M 10-K · filed 2017-03-31 | ||
| 2016-09-30 | $1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $6.97M derived: sum of 2 quarters · filed 2017-11-14 | $17.25M 10-Q · filed 2017-11-14 | |||
| 2016-06-30 | $5.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $16.24M 10-Q · filed 2017-08-14 | ||||
| 2016-03-31 | $10.28M 10-Q · filed 2017-05-15 | |||||
| 2015-12-31 | $0.00 10-K · filed 2017-03-31 | |||||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $0.00 10-Q · filed 2016-08-15 | ||||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-13 | |||||
| 2012-06-30 | $0.00 10-Q · filed 2012-08-14 | |||||
| 2011-06-30 | $964.66K 10-Q · filed 2012-08-14 |